The seven pharmaceutical companies have opened up sections of their compound libraries and agreed to share data with each other and the research institutions under the Gates Foundation's TB Drug Accelerator (TBDA) program to discover treatments for tuberculosis (TB). The program shifted last year to implementing assays and tools into a drug discovery effort from building the assays...